HPV genotype distribution in cervical intraepithelial Neoplasia among HIV-infected women in Pune, India

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Mane, Arati ^a   Nirmalkar, Amit ^a   Risbud, Arun R ^a   Vermund, Sten H ^b   Mehendale, Sanjay M ^c   Sahasrabuddhe, Vikrant V ^b  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c National Institute of Epidemiology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; COLPOSCOPY; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; GENOTYPE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN TISSUE; INDIA; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PAPILLOMA VIRUS; PREVALENCE; SEXUALITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

ADULT; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; INDIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS;

EID: 84862546194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038731     Document Type: Article

References (43)

1. Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, et al. (2010) Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One 5: e8634.
2. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, et al. (2005) Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586.
3. Palefsky JM, Holly EA, (2003) Chapter 6: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr pp. 41-46.
4. Peedicayil A, Thiyagarajan K, Gnanamony M, Pulimood SA, Jeyaseelan V, et al. (2009) Prevalence and risk factors for human papillomavirus and cervical intraepithelial neoplasia among HIV-positive women at a tertiary level hospital in India. J Low Genit Tract Dis 13: 159-164.
5. Sarkar K, Pal R, Bal B, Saha B, Bhattacharya S, et al. (2011) Oncogenic HPV among HIV infected female population in West Bengal, India. BMC Infect Dis 11: 72.
6. Joshi SN, Gopalkrishna V, Kumar BK, Dutta S, Nyaynirgune P, et al. (2005) Cervical squamous intra-epithelial changes and human papillomavirus infection in women infected with human immunodeficiency virus in Pune, India. J Med Virol 76: 470-475.
7. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, et al. (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287: 2114-2119.
8. Richart RM, (1990) A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 75: 131-133.
9. Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, et al. (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40: 902-907.
10. Coutlee F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, et al. (2006) Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol 44: 1998-2006.
11. Kornegay JR, Roger M, Davies PO, Shepard AP, Guerrero NA, et al. (2003) International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbiol 41: 1080-1086.
12. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, et al. (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol 10: 321-322.
13. Clifford GM, Goncalves MA, Franceschi S, (2006) Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 20: 2337-2344.
14. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, et al. (2007) Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 96: 1480-1483.
15. Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, et al. (2009) Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis 199: 1851-1861.
16. Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, et al. (2009) Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer 9: 275.
17. Didelot-Rousseau MN, Nagot N, Costes-Martineau V, Valles X, Ouedraogo A, et al. (2006) Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer 95: 355-362.
18. Bollen LJ, Chuachoowong R, Kilmarx PH, Mock PA, Culnane M, et al. (2006) Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization. Sex Transm Dis 33: 259-264.
19. Hernandez BY, Vu Nguyen T, (2008) Cervical human papillomavirus infection among female sex workers in southern Vietnam. Infect Agent Cancer 3: 7.
20. Melgaco FG, Rosa ML, Augusto EF, Haimuri JG, Jacintho C, et al. (2011) Human papillomavirus genotypes distribution in cervical samples from women living with human immunodeficiency virus. Arch Gynecol Obstet 283: 809-817.
21. Coelho Lima BM, Golub JE, Tonani Mattos A, Freitas LB, Cruz Spano L, et al. (2009) Human papillomavirus in women with and without HIV-1 infection attending an STI clinic in Vitoria, Brazil. J Int Assoc Physicians AIDS Care (Chic) 8: 286-290.
22. Tornesello ML, Duraturo ML, Giorgi-Rossi P, Sansone M, Piccoli R, et al. (2008) Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol 89: 1380-1389.
23. Kitchener H, Nelson L, Adams J, Mesher D, Sasieni P, et al. (2007) Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer 121: 2484-2491.
24. Hankins C, Coutlee F, Lapointe N, Simard P, Tran T, et al. (1999) Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ 160: 185-191.
25. Luque AE, Jabeen M, Messing S, Lane CA, Demeter LM, et al. (2006) Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 194: 428-434.
26. Strickler HD, Palefsky JM, Burk RD, (2008) HPV types present in invasive cervical cancers of HIV-seropositive women. Int J Cancer 123: 1224-1225.
27. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, et al. (2003) Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 95: 1062-1071.
28. McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA 3rd (2010) Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol 116: 572-577.
29. Broker TR, Jin G, Croom-Rivers A, Bragg SM, Richardson M, et al. (2001) Viral latency-the papillomavirus model. Dev Biol (Basel) 106: 443-451; discussion 452-443, 465-475.
30. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, et al. (1999) Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 91: 226-236.
31. Nicol AF, Nuovo GJ, Salomao-Estevez A, Grinsztejn B, Tristao A, et al. (2008) Immune factors involved in the cervical immune response in the HIV/HPV co-infection. J Clin Pathol 61: 84-88.
32. Stanley M, (2010) Prospects for new human papillomavirus vaccines. Curr Opin Infect Dis 23: 70-75.
33. Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, et al. (2002) High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 40: 3341-3345.
34. Luque AE, Hitti J, Mwachari C, Lane C, Messing S, et al. (2010) Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). Int J Infect Dis 14: e810-814.
35. Hawes SE, Critchlow CW, Sow PS, Toure P, N'Doye I, et al. (2006) Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst 98: 100-109.
36. Moscicki AB, Ellenberg JH, Farhat S, Xu J, (2004) Persistence of human papillomavirus infection in HIV-infected and-uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 190: 37-45.
37. Nuovo GJ, Darfler MM, Impraim CC, Bromley SE, (1991) Occurrence of multiple types of human papillomavirus in genital tract lesions. Analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol 138: 53-58.
38. Vaccarella S, Franceschi S, Snijders PJ, Herrero R, Meijer CJ, et al. (2010) Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 19: 503-510.
39. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, et al. (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125: 2151-2158.
40. Steinau M, Swan DC, Unger ER, (2008) Type-specific reproducibility of the Roche linear array HPV genotyping test. J Clin Virol 42: 412-414.
41. Joint United Nations Programme on HIV/AIDS (2010) Global report: UNAIDS report on the global AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS. pp. v.
42. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
43. Sahasrabuddhe VV, Luhn P, Wentzensen N, (2011) Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol 6: 1083-1098.